Genomic tests using next generation sequencing technologies are increasingly being offered in a range of clinical settings, but with the current reimbursement environment not structured to recognize the value, many patients and clinicians to not have access to them. How can this be changed? Read more here. (Source: Glenna Picton, Baylor College of Medicine, 11/11/14).
You are here: / / Can Clinical Genome Sequencing Tests Overcome Reimbursement Barriers?